AVBP ArriVent BioPharma, Inc. - Common Stock
$26,80
Prezzo · Mag 20, 2026
Fondamentali al Mag 11, 2026
Intervallo 52 sett.
$16–$32
67% of range
Rating Analisti
BUY
19 analysts
Prezzo Obiettivo
$42
+56% upside
P/E (TTM)
-4.7
ROE
-59.7%
Margine di Profitto Netto
—
AVBP Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$26.80
Capitalizzazione di Mercato
$854M
P/E (TTM)
-4.7
EPS (TTM)
$-4.32
Ricavi (TTM)
—
Rendimento div.
—
ROE
-59.7%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$16 – $32
AVBP Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-4.32
2023-12-31
→
2025-12-31
Flusso di cassa libero
—
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
AVBP
Mediana dei peer
P/E (TTM)
-4.7
—
P/B
2.8
7.4
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
AVBP
Mediana dei peer
ROA
-54.7%
-47.6%
ROE
-59.7%
-62.8%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
AVBP
Mediana dei peer
Current Ratio (Rapporto corrente)
12.8
5.6
Quick Ratio
12.1
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
AVBP
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
AVBP
Mediana dei peer
AVBP Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
19 analisti
- Acquisto forte 7 36,8%
- Compra 11 57,9%
- Mantieni 1 5,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
12 analisti · 2026-05-20
Mediana
$43.50
Ora
$26.80
Basso
$25.25
Alto
$50.00
Target mediano
$43.50
+62,3%
Target medio
$41.94
+56,5%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.28%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.96 | $-0.91 | -0.05% |
| 31 Dicembre 2025 | $-0.78 | $-0.86 | 0.08% |
| 30 Settembre 2025 | $-0.83 | $-0.81 | -0.02% |
| 30 Giugno 2025 | $-0.90 | $-0.72 | -0.18% |
| 31 Marzo 2025 | $-1.90 | $-0.68 | -1.2% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| KALV | $685M | -3.7 | — | — | -172.9% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 10
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $153M | $79M | $65M | |
| SG&A Expense | $24M | $15M | $10M | |
| Operating Expenses | $178M | $94M | $75M | |
| Operating Income | $-178M | $-94M | $-75M | |
| Net Income | $-166M | $-80M | $-69M | |
| EPS (Basic) | $-4.32 | $-2.56 | $-32.38 | |
| EPS (Diluted) | $-4.32 | $-2.56 | $-32.38 | |
| Shares (Basic) | 38,462,600 | 31,469,328 | 2,140,951 | |
| Shares (Diluted) | 38,462,600 | 31,469,328 | 2,140,951 | |
| EBITDA | $-181M | $-94M | · |
Stato Patrimoniale 18
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $46M | $74M | $150M | |
| Short-term Investments | $267M | $145M | · | |
| Prepaid Expense | $20M | $8M | $10M | |
| Current Assets | $333M | $227M | $160M | |
| Other Non-current Assets | $190.0K | $126.0K | $107.0K | |
| Total Assets | $333M | $275M | $163M | |
| Accounts Payable | $6M | $4M | $5M | |
| Accrued Liabilities | $20M | $13M | $7M | |
| Current Liabilities | $26M | $17M | $12M | |
| Capital Leases | · | $14.0K | $177.0K | |
| Total Liabilities | $26M | $17M | $12M | |
| Common Stock | $4.0K | $3.0K | · | |
| Paid-in Capital | $712M | $496M | $5M | |
| Retained Earnings | $-405M | $-238M | $-158M | |
| AOCI | $14.0K | $-211.0K | · | |
| Stockholders' Equity | $307M | $258M | $-153M | |
| Liabilities + Equity | $333M | $275M | $163M | |
| Shares Outstanding | 42,452,251 | 33,706,765 | 2,745,480 |
Flusso di cassa 10
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $-3M | · | · | |
| Stock-based Comp | $13M | $3M | $895.0K | |
| Other Non-cash | $-4M | · | · | |
| Operating Cash Flow | $-161M | $-70M | $-56M | |
| Investing Cash Flow | $-71M | $-192M | · | |
| Stock Issued | $203M | $186M | · | |
| Net Stock Activity | $203M | · | · | |
| Financing Cash Flow | $203M | $187M | $43M | |
| Net Change in Cash | $-29M | $-76M | $-13M | |
| Taxes Paid | $0 | · | · |
Redditività 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -54.7% | -36.8% | · | |
| ROE | -59.7% | -30.1% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.8 | 13.1 | · | |
| Quick Ratio | 12.1 | 12.7 | · |
Valutazione (TTM) 7
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-166M | $-80M | $-69M | |
| Market Cap | $854M | $898M | · | |
| P/E | -4.7 | -10.4 | · | |
| P/B | 2.8 | 3.5 | · | |
| P / Tangible Book | 2.8 | 3.5 | · | |
| P / Cash Flow | -5.3 | -12.8 | · | |
| Earnings Yield | -21.5% | -9.6% | · |
Conto Economico 11
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $38M | $32M | $32M | $28M | $61M | $20M | $20M | $22M | $17M | $20M | |
| SG&A Expense | $8M | $7M | $6M | $6M | $5M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $46M | $39M | $38M | $34M | $67M | $24M | $24M | $26M | $21M | $23M | |
| Operating Income | $-46M | $-39M | $-38M | $-34M | $-67M | $-24M | $-24M | $-26M | $-21M | $-23M | |
| Interest Income | · | · | · | · | · | · | $4M | $4M | $3M | · | |
| Net Income | $-43M | $-36M | $-35M | $-31M | $-64M | $-21M | $-21M | $-22M | $-17M | $-21M | |
| EPS (Basic) | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | |
| EPS (Diluted) | $-0.96 | $-0.69 | $-0.83 | $-0.90 | $-1.90 | $-0.60 | $-0.61 | $-0.65 | $-0.70 | $-6.62 | |
| Shares (Basic) | 45,067,658 | -72,355,289 | 41,912,905 | 35,006,114 | 33,898,870 | -60,661,360 | 33,581,810 | 33,502,347 | 25,046,531 | -3,753,520 | |
| Shares (Diluted) | 45,067,658 | -72,355,289 | 41,912,905 | 35,006,114 | 33,898,870 | -60,661,360 | 33,581,810 | 33,502,347 | 25,046,531 | -3,753,520 | |
| EBITDA | $-47M | · | $-38M | $-34M | $-67M | · | $-24M | $-26M | $-21M | · |
Stato Patrimoniale 18
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $62M | $46M | $113M | $113M | $50M | $74M | $283M | $299M | $317M | $150M | |
| Short-term Investments | $264M | $267M | $188M | $123M | $126M | $145M | · | · | · | · | |
| Prepaid Expense | $22M | $20M | $21M | $14M | $10M | $8M | $10M | $10M | $10M | $10M | |
| Current Assets | $349M | $333M | $321M | $250M | $186M | $227M | $292M | $309M | $327M | $160M | |
| Other Non-current Assets | $156.0K | $190.0K | $180.0K | $479.0K | $176.0K | $126.0K | $126.0K | $125.0K | $108.0K | $107.0K | |
| Total Assets | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | |
| Accounts Payable | $9M | $6M | $6M | $4M | $4M | $4M | $5M | $4M | $4M | $5M | |
| Accrued Liabilities | $16M | $20M | $16M | $15M | $8M | $13M | $10M | $8M | $6M | $7M | |
| Current Liabilities | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | |
| Capital Leases | $320.0K | · | · | · | · | $14.0K | $56.0K | $98.0K | $138.0K | $177.0K | |
| Total Liabilities | $25M | $26M | $22M | $20M | $13M | $17M | $15M | $12M | $10M | $12M | |
| Common Stock | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | |
| Paid-in Capital | $772M | $712M | $674M | $584M | $505M | $496M | $495M | $494M | $493M | $5M | |
| Retained Earnings | $-448M | $-405M | $-369M | $-334M | $-303M | $-238M | $-218M | $-197M | $-175M | $-158M | |
| AOCI | $-270.0K | $14.0K | $206.0K | $-18.0K | $-17.0K | $-211.0K | · | · | · | · | |
| Stockholders' Equity | $324M | $307M | $305M | $250M | $203M | $258M | $277M | $297M | $318M | $-153M | |
| Liabilities + Equity | $349M | $333M | $327M | $270M | $215M | $275M | $293M | $309M | $328M | $163M | |
| Shares Outstanding | 45,308,941 | 42,452,251 | 40,852,312 | 37,490,439 | 34,040,996 | 33,706,765 | 33,694,355 | 33,509,090 | 33,493,750 | 2,745,480 |
Flusso di cassa 9
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-559.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $5M | $3M | $4M | $3M | $2M | $952.0K | $866.0K | $765.0K | $625.0K | $319.0K | |
| Other Non-cash | $-3M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-31M | $-36M | $-26M | $-68M | $-16M | $-16M | $-19M | $-19M | $-15M | |
| Investing Cash Flow | $4M | $-71M | $-51M | $14M | $37M | · | · | · | · | · | |
| Stock Issued | $55M | $35M | · | · | $7M | $0 | · | · | $186M | · | |
| Net Stock Activity | $55M | · | · | · | · | · | · | · | $186M | · | |
| Financing Cash Flow | $55M | $35M | $86M | $75M | $7M | $55.0K | $531.0K | $363.0K | $186M | $-1M | |
| Net Change in Cash | $17M | $-67M | $-93.0K | $63M | $-24M | $-209M | $-16M | $-19M | $167M | $9M |
Redditività 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.3% | · | -11.3% | -10.9% | -23.7% | · | -14.1% | -14.2% | -10.6% | · | |
| ROE | -16.5% | · | -12.0% | -11.5% | -24.8% | · | -14.8% | -14.8% | -11.0% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.0 | · | 14.9 | 12.7 | 14.3 | · | 19.3 | 25.5 | 32.8 | · | |
| Quick Ratio | 13.1 | · | 13.9 | 12.0 | 13.6 | · | 18.7 | 24.7 | 31.8 | · |
Valutazione (TTM) 7
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-174M | · | $-151M | $-138M | $-124M | · | $-74M | $-75M | $-66M | · | |
| Market Cap | $1.05B | · | $754M | $816M | $629M | · | $792M | $622M | $598M | · | |
| P/E | -5.0 | · | -4.4 | -5.4 | -4.8 | · | -3.1 | -1.1 | -0.7 | · | |
| P/B | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | |
| P / Tangible Book | 3.2 | · | 2.5 | 3.3 | 3.1 | · | 2.9 | 2.1 | 1.9 | · | |
| P / Cash Flow | -25.0 | · | · | · | -9.3 | · | · | · | -32.1 | · | |
| Earnings Yield | -19.9% | · | -23.0% | -18.6% | -20.9% | · | -31.8% | -95.2% | -148.2% | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Utile netto | $-166M | $-80M | $-69M |
| EPS Diluito | $-4.32 | $-2.56 | $-32.38 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Rapporto corrente | 12.8 | 13.1 | — |
| Quick Ratio | 12.1 | 12.7 | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.